ID

35585

Description

Medtronic RevElution Trial; ODM derived from: https://clinicaltrials.gov/show/NCT02480348

Link

https://clinicaltrials.gov/show/NCT02480348

Keywords

Versions (1)
  1. 3/11/19 3/11/19 -
Copyright Holder

See clinicaltrials.gov

Uploaded on

March 11, 2019

DOI

To request one please log in.

License

Creative Commons BY 4.0
Model comments :

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Back to model comments
Itemgroup comments for :

Item comments for :

In order to download data models you must be logged in. Please log in or register for free.

Eligibility Coronary Artery Disease NCT02480348

English

Eligibility Coronary Artery Disease NCT02480348

1 forms  
Inclusion Criteria
Description

Inclusion Criteria

Alias
UMLS CUI
C1512693
must be an acceptable candidate for percutaneous coronary intervention, stenting, &
Description

Patient Acceptable Percutaneous Coronary Intervention | Patient Acceptable Stenting

Data type

boolean

Alias
UMLS CUI [1,1]
C0030705
UMLS CUI [1,2]
C1879533
UMLS CUI [1,3]
C1532338
UMLS CUI [2,1]
C0030705
UMLS CUI [2,2]
C1879533
UMLS CUI [2,3]
C2348535
emergent coronary artery bypass graft (cabg) surgery
Description

Patient Acceptable Emergency CABG

Data type

boolean

Alias
UMLS CUI [1,1]
C0030705
UMLS CUI [1,2]
C1879533
UMLS CUI [1,3]
C1532296
must have evidence of ischemic heart disease
Description

Myocardial Ischemia

Data type

boolean

Alias
UMLS CUI [1]
C0151744
must require treatment of either a) a single target lesion amenable to treatment with a 2.25 mm - 3.50 mm stent or b) two target lesions located in separate target vessels, with at least one of the target lesions amenable to treatment with a 2.25 mm- 3.50 mm mm study stent
Description

Target Lesion Single Amenable Stent | Target Lesion Quantity | Location Target vessel Separate | Target Lesion Amenable Stent

Data type

boolean

Alias
UMLS CUI [1,1]
C2986546
UMLS CUI [1,2]
C0205171
UMLS CUI [1,3]
C3900053
UMLS CUI [1,4]
C0038257
UMLS CUI [2,1]
C2986546
UMLS CUI [2,2]
C1265611
UMLS CUI [3,1]
C1515974
UMLS CUI [3,2]
C0449618
UMLS CUI [3,3]
C0443299
UMLS CUI [4,1]
C2986546
UMLS CUI [4,2]
C3900053
UMLS CUI [4,3]
C0038257
target lesion(s) must be de novo lesion(s) in native coronary artery(ies)
Description

Target Lesion de novo | Location Coronary artery Native

Data type

boolean

Alias
UMLS CUI [1,1]
C1521840
UMLS CUI [1,2]
C0221198
UMLS CUI [1,3]
C1515568
UMLS CUI [2,1]
C1515974
UMLS CUI [2,2]
C0205042
UMLS CUI [2,3]
C0302891
Exclusion Criteria
Description

Exclusion Criteria

Alias
UMLS CUI
C0680251
known hypersensitivity or contraindication to aspirin, heparin and bivalirudin, thienopyridines, cobalt, nickel, platinum, iridium, chromium, molybdenum, polymer coatings (e.g. biolinx) or a sensitivity to contrast media, which cannot be adequately pre-medicated
Description

Aspirin allergy | Medical contraindication Aspirin | Heparin allergy | Medical contraindication Heparin | Hypersensitivity Bivalirudin | Medical contraindication Bivalirudin | Hypersensitivity Thienopyridines | Medical contraindication Thienopyridines | Hypersensitivity Cobalt | Medical contraindication Cobalt | Allergy to nickel | Medical contraindication Nickel | Hypersensitivity Platinum | Medical contraindication Platinum | Hypersensitivity Iridium | Medical contraindication Iridium | Hypersensitivity Chromium | Medical contraindication Chromium | Hypersensitivity Molybdenum | Medical contraindication Molybdenum | Hypersensitivity Polymers Coating | Medical contraindication Polymers Coating | Contrast media allergy

Data type

boolean

Alias
UMLS CUI [1]
C0004058
UMLS CUI [2,1]
C1301624
UMLS CUI [2,2]
C0004057
UMLS CUI [3]
C0571776
UMLS CUI [4,1]
C1301624
UMLS CUI [4,2]
C0019134
UMLS CUI [5,1]
C0020517
UMLS CUI [5,2]
C0168273
UMLS CUI [6,1]
C1301624
UMLS CUI [6,2]
C0168273
UMLS CUI [7,1]
C0020517
UMLS CUI [7,2]
C2936588
UMLS CUI [8,1]
C1301624
UMLS CUI [8,2]
C2936588
UMLS CUI [9,1]
C0020517
UMLS CUI [9,2]
C0009148
UMLS CUI [10,1]
C1301624
UMLS CUI [10,2]
C0009148
UMLS CUI [11]
C1690547
UMLS CUI [12,1]
C1301624
UMLS CUI [12,2]
C0028013
UMLS CUI [13,1]
C0020517
UMLS CUI [13,2]
C0032207
UMLS CUI [14,1]
C1301624
UMLS CUI [14,2]
C0032207
UMLS CUI [15,1]
C0020517
UMLS CUI [15,2]
C0022071
UMLS CUI [16,1]
C1301624
UMLS CUI [16,2]
C0022071
UMLS CUI [17,1]
C0020517
UMLS CUI [17,2]
C0008574
UMLS CUI [18,1]
C1301624
UMLS CUI [18,2]
C0008574
UMLS CUI [19,1]
C0020517
UMLS CUI [19,2]
C0026402
UMLS CUI [20,1]
C1301624
UMLS CUI [20,2]
C0026402
UMLS CUI [21,1]
C0020517
UMLS CUI [21,2]
C0032521
UMLS CUI [21,3]
C1522408
UMLS CUI [22,1]
C1301624
UMLS CUI [22,2]
C0032521
UMLS CUI [22,3]
C1522408
UMLS CUI [23]
C0570562
history of an allergic reaction or significant sensitivity to drugs such as zotarolimus, rapamycin, tacrolimus, everolimus, or any other analogue or derivative
Description

Allergic Reaction Zotarolimus | Hypersensitivity Zotarolimus | Allergic Reaction Sirolimus | Hypersensitivity Sirolimus | Allergic Reaction Tacrolimus | Hypersensitivity Tacrolimus | Allergic Reaction Everolimus | Hypersensitivity Everolimus | Allergic Reaction Analogue Any | Hypersensitivity Analogue Any | Allergic Reaction Derivative Any | Hypersensitivity Derivative Any

Data type

boolean

Alias
UMLS CUI [1,1]
C1527304
UMLS CUI [1,2]
C1700035
UMLS CUI [2,1]
C0020517
UMLS CUI [2,2]
C1700035
UMLS CUI [3,1]
C1527304
UMLS CUI [3,2]
C0072980
UMLS CUI [4,1]
C0020517
UMLS CUI [4,2]
C0072980
UMLS CUI [5,1]
C1527304
UMLS CUI [5,2]
C0085149
UMLS CUI [6,1]
C0020517
UMLS CUI [6,2]
C0085149
UMLS CUI [7,1]
C1527304
UMLS CUI [7,2]
C0541315
UMLS CUI [8,1]
C0020517
UMLS CUI [8,2]
C0541315
UMLS CUI [9,1]
C1527304
UMLS CUI [9,2]
C0243071
UMLS CUI [9,3]
C1552551
UMLS CUI [10,1]
C0020517
UMLS CUI [10,2]
C0243071
UMLS CUI [10,3]
C1552551
UMLS CUI [11,1]
C1527304
UMLS CUI [11,2]
C1527240
UMLS CUI [11,3]
C1552551
UMLS CUI [12,1]
C0020517
UMLS CUI [12,2]
C1527240
UMLS CUI [12,3]
C1552551
history of a stroke or transient ischemic attack (tia) within the prior 6 months
Description

Cerebrovascular accident | Transient Ischemic Attack

Data type

boolean

Alias
UMLS CUI [1]
C0038454
UMLS CUI [2]
C0007787
active peptic ulcer or upper gastrointestinal (gi) bleeding within the prior 6 months
Description

Peptic Ulcer | Upper gastrointestinal hemorrhage

Data type

boolean

Alias
UMLS CUI [1]
C0030920
UMLS CUI [2]
C0041909
history of bleeding diathesis or coagulopathy or will refuse blood transfusions
Description

Bleeding tendency | Blood Coagulation Disorders | Blood Transfusion Refused

Data type

boolean

Alias
UMLS CUI [1]
C1458140
UMLS CUI [2]
C0005779
UMLS CUI [3,1]
C0005841
UMLS CUI [3,2]
C1705116
concurrent medical condition with a life expectancy of less than 5 years
Description

Comorbidity | Life Expectancy

Data type

boolean

Alias
UMLS CUI [1]
C0009488
UMLS CUI [2]
C0023671
currently participating in an investigational drug or another device trial that has not completed the primary endpoint
Description

Study Subject Participation Status | Investigational New Drugs | Investigational Medical Device | End Point Primary Incomplete

Data type

boolean

Alias
UMLS CUI [1]
C2348568
UMLS CUI [2]
C0013230
UMLS CUI [3]
C2346570
UMLS CUI [4,1]
C2349179
UMLS CUI [4,2]
C0205225
UMLS CUI [4,3]
C0205257
documented left ventricular ejection fraction (lvef) < 30% at the most recent evaluation
Description

Left ventricular ejection fraction

Data type

boolean

Alias
UMLS CUI [1]
C0428772
Back to the top of the page

Similar models

Eligibility Coronary Artery Disease NCT02480348

1 forms
Name
Type
Description | Question | Decode (Coded Value)
Data type
Alias
Item Group
C1512693 (UMLS CUI)
Patient Acceptable Percutaneous Coronary Intervention | Patient Acceptable Stenting
Item
must be an acceptable candidate for percutaneous coronary intervention, stenting, &
boolean
C0030705 (UMLS CUI [1,1])
C1879533 (UMLS CUI [1,2])
C1532338 (UMLS CUI [1,3])
C0030705 (UMLS CUI [2,1])
C1879533 (UMLS CUI [2,2])
C2348535 (UMLS CUI [2,3])
Patient Acceptable Emergency CABG
Item
emergent coronary artery bypass graft (cabg) surgery
boolean
C0030705 (UMLS CUI [1,1])
C1879533 (UMLS CUI [1,2])
C1532296 (UMLS CUI [1,3])
Myocardial Ischemia
Item
must have evidence of ischemic heart disease
boolean
C0151744 (UMLS CUI [1])
Target Lesion Single Amenable Stent | Target Lesion Quantity | Location Target vessel Separate | Target Lesion Amenable Stent
Item
must require treatment of either a) a single target lesion amenable to treatment with a 2.25 mm - 3.50 mm stent or b) two target lesions located in separate target vessels, with at least one of the target lesions amenable to treatment with a 2.25 mm- 3.50 mm mm study stent
boolean
C2986546 (UMLS CUI [1,1])
C0205171 (UMLS CUI [1,2])
C3900053 (UMLS CUI [1,3])
C0038257 (UMLS CUI [1,4])
C2986546 (UMLS CUI [2,1])
C1265611 (UMLS CUI [2,2])
C1515974 (UMLS CUI [3,1])
C0449618 (UMLS CUI [3,2])
C0443299 (UMLS CUI [3,3])
C2986546 (UMLS CUI [4,1])
C3900053 (UMLS CUI [4,2])
C0038257 (UMLS CUI [4,3])
Target Lesion de novo | Location Coronary artery Native
Item
target lesion(s) must be de novo lesion(s) in native coronary artery(ies)
boolean
C1521840 (UMLS CUI [1,1])
C0221198 (UMLS CUI [1,2])
C1515568 (UMLS CUI [1,3])
C1515974 (UMLS CUI [2,1])
C0205042 (UMLS CUI [2,2])
C0302891 (UMLS CUI [2,3])
Item Group
C0680251 (UMLS CUI)
Aspirin allergy | Medical contraindication Aspirin | Heparin allergy | Medical contraindication Heparin | Hypersensitivity Bivalirudin | Medical contraindication Bivalirudin | Hypersensitivity Thienopyridines | Medical contraindication Thienopyridines | Hypersensitivity Cobalt | Medical contraindication Cobalt | Allergy to nickel | Medical contraindication Nickel | Hypersensitivity Platinum | Medical contraindication Platinum | Hypersensitivity Iridium | Medical contraindication Iridium | Hypersensitivity Chromium | Medical contraindication Chromium | Hypersensitivity Molybdenum | Medical contraindication Molybdenum | Hypersensitivity Polymers Coating | Medical contraindication Polymers Coating | Contrast media allergy
Item
known hypersensitivity or contraindication to aspirin, heparin and bivalirudin, thienopyridines, cobalt, nickel, platinum, iridium, chromium, molybdenum, polymer coatings (e.g. biolinx) or a sensitivity to contrast media, which cannot be adequately pre-medicated
boolean
C0004058 (UMLS CUI [1])
C1301624 (UMLS CUI [2,1])
C0004057 (UMLS CUI [2,2])
C0571776 (UMLS CUI [3])
C1301624 (UMLS CUI [4,1])
C0019134 (UMLS CUI [4,2])
C0020517 (UMLS CUI [5,1])
C0168273 (UMLS CUI [5,2])
C1301624 (UMLS CUI [6,1])
C0168273 (UMLS CUI [6,2])
C0020517 (UMLS CUI [7,1])
C2936588 (UMLS CUI [7,2])
C1301624 (UMLS CUI [8,1])
C2936588 (UMLS CUI [8,2])
C0020517 (UMLS CUI [9,1])
C0009148 (UMLS CUI [9,2])
C1301624 (UMLS CUI [10,1])
C0009148 (UMLS CUI [10,2])
C1690547 (UMLS CUI [11])
C1301624 (UMLS CUI [12,1])
C0028013 (UMLS CUI [12,2])
C0020517 (UMLS CUI [13,1])
C0032207 (UMLS CUI [13,2])
C1301624 (UMLS CUI [14,1])
C0032207 (UMLS CUI [14,2])
C0020517 (UMLS CUI [15,1])
C0022071 (UMLS CUI [15,2])
C1301624 (UMLS CUI [16,1])
C0022071 (UMLS CUI [16,2])
C0020517 (UMLS CUI [17,1])
C0008574 (UMLS CUI [17,2])
C1301624 (UMLS CUI [18,1])
C0008574 (UMLS CUI [18,2])
C0020517 (UMLS CUI [19,1])
C0026402 (UMLS CUI [19,2])
C1301624 (UMLS CUI [20,1])
C0026402 (UMLS CUI [20,2])
C0020517 (UMLS CUI [21,1])
C0032521 (UMLS CUI [21,2])
C1522408 (UMLS CUI [21,3])
C1301624 (UMLS CUI [22,1])
C0032521 (UMLS CUI [22,2])
C1522408 (UMLS CUI [22,3])
C0570562 (UMLS CUI [23])
Allergic Reaction Zotarolimus | Hypersensitivity Zotarolimus | Allergic Reaction Sirolimus | Hypersensitivity Sirolimus | Allergic Reaction Tacrolimus | Hypersensitivity Tacrolimus | Allergic Reaction Everolimus | Hypersensitivity Everolimus | Allergic Reaction Analogue Any | Hypersensitivity Analogue Any | Allergic Reaction Derivative Any | Hypersensitivity Derivative Any
Item
history of an allergic reaction or significant sensitivity to drugs such as zotarolimus, rapamycin, tacrolimus, everolimus, or any other analogue or derivative
boolean
C1527304 (UMLS CUI [1,1])
C1700035 (UMLS CUI [1,2])
C0020517 (UMLS CUI [2,1])
C1700035 (UMLS CUI [2,2])
C1527304 (UMLS CUI [3,1])
C0072980 (UMLS CUI [3,2])
C0020517 (UMLS CUI [4,1])
C0072980 (UMLS CUI [4,2])
C1527304 (UMLS CUI [5,1])
C0085149 (UMLS CUI [5,2])
C0020517 (UMLS CUI [6,1])
C0085149 (UMLS CUI [6,2])
C1527304 (UMLS CUI [7,1])
C0541315 (UMLS CUI [7,2])
C0020517 (UMLS CUI [8,1])
C0541315 (UMLS CUI [8,2])
C1527304 (UMLS CUI [9,1])
C0243071 (UMLS CUI [9,2])
C1552551 (UMLS CUI [9,3])
C0020517 (UMLS CUI [10,1])
C0243071 (UMLS CUI [10,2])
C1552551 (UMLS CUI [10,3])
C1527304 (UMLS CUI [11,1])
C1527240 (UMLS CUI [11,2])
C1552551 (UMLS CUI [11,3])
C0020517 (UMLS CUI [12,1])
C1527240 (UMLS CUI [12,2])
C1552551 (UMLS CUI [12,3])
Cerebrovascular accident | Transient Ischemic Attack
Item
history of a stroke or transient ischemic attack (tia) within the prior 6 months
boolean
C0038454 (UMLS CUI [1])
C0007787 (UMLS CUI [2])
Peptic Ulcer | Upper gastrointestinal hemorrhage
Item
active peptic ulcer or upper gastrointestinal (gi) bleeding within the prior 6 months
boolean
C0030920 (UMLS CUI [1])
C0041909 (UMLS CUI [2])
Bleeding tendency | Blood Coagulation Disorders | Blood Transfusion Refused
Item
history of bleeding diathesis or coagulopathy or will refuse blood transfusions
boolean
C1458140 (UMLS CUI [1])
C0005779 (UMLS CUI [2])
C0005841 (UMLS CUI [3,1])
C1705116 (UMLS CUI [3,2])
Comorbidity | Life Expectancy
Item
concurrent medical condition with a life expectancy of less than 5 years
boolean
C0009488 (UMLS CUI [1])
C0023671 (UMLS CUI [2])
Study Subject Participation Status | Investigational New Drugs | Investigational Medical Device | End Point Primary Incomplete
Item
currently participating in an investigational drug or another device trial that has not completed the primary endpoint
boolean
C2348568 (UMLS CUI [1])
C0013230 (UMLS CUI [2])
C2346570 (UMLS CUI [3])
C2349179 (UMLS CUI [4,1])
C0205225 (UMLS CUI [4,2])
C0205257 (UMLS CUI [4,3])
Left ventricular ejection fraction
Item
documented left ventricular ejection fraction (lvef) < 30% at the most recent evaluation
boolean
C0428772 (UMLS CUI [1])
Back to the top of the page 

Contact

Please use this form for feedback, questions and suggestions for improvements.

Fields marked with * are required.

Help

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial